γ-Aminobutyric Acid Transporter 1 Negatively Regulates T Cell-Mediated Immune Responses and Ameliorates Autoimmune Inflammation in the CNS
- 15 December 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 181 (12) , 8226-8236
Abstract
γ-aminobutyric acid (GABA) is the major inhibitory neurotransmitter of the CNS, and GABA transporter 1 (GAT-1) is critical in maintaining a GABA reservoir and associated functions. The wide expression of GAT-1 in the CNS prompted us to explore its role in neuroimmunological disorders. In mice induced with experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis, we found that the expression levels of GAT-1 mRNA and protein in spinal cord were greatly suppressed as compared with those in naive mice and irrelevant Ag-immunized mice. Therefore, we induced EAE in GAT-1−/− mice and found that the disease was significantly aggravated and was accompanied by some nonclassic EAE signs. Mononuclear cells from GAT-1−/− mice with EAE showed much higher Ag-specific proliferative responses. Proinflammatory cytokine production in these mice was also greatly up-regulated. Further studies revealed that GAT-1 deficiency induced vigorous immune responses by enhancing IκB kinase phosphorylation and NF-κB-DNA binding activity, as well as strengthening the T-bet-STAT1 circuit signaling pathway. Finally, we found that GAT-1 was expressed only on activated T cells primed with Ags, but not on B cells or macrophages. These findings indicate that GAT-1 is a critical modulator in T cell-mediated immune responses and in EAE pathogenesis.Keywords
This publication has 47 references indexed in Scilit:
- Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responsesClinical and Experimental Immunology, 2007
- Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cellsNature Immunology, 2006
- T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotypeBlood, 2006
- Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotectionProceedings of the National Academy of Sciences, 2006
- Author Index Vol. 59, 2003Hormone Research in Paediatrics, 2003
- Administration of the 5-hydroxytryptamine(1A) receptor antagonist WAY100635 suppresses acute experimental allergic encephalomyelitis in Lewis ratsNeuroscience Letters, 2003
- T Cell Response in Experimental Autoimmune Encephalomyelitis (EAE): Role of Self and Cross-Reactive Antigens in Shaping, Tuning, and Regulating the Autopathogenic T Cell RepertoireAnnual Review of Immunology, 2002
- Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous SystemCell, 1996
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- The T Lymphocyte in Experimental Allergic EncephalomyelitisAnnual Review of Immunology, 1990